BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals





 Company News
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014 6:47:44 AM    More...
Astellas Pharma Inc. (ALPMY) And Daiichi Sankyo, Inc. (4568.t) Form Compound Library Sharing Partnership 3/20/2014 10:13:49 AM    More...
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Submit Supplemental New Drug Application For XTANDI (Enzalutamide) For Chemotherapy-Naive Advanced Prostate Cancer 3/18/2014 9:57:54 AM    More...
Cumberland Pharmaceuticals (CPIX) Acquires Vaprisol® From Astellas Pharma Inc. (ALPMY) 3/3/2014 11:05:27 AM    More...
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Mucormycosis 2/27/2014 9:55:22 AM    More...
Astellas Pharma Inc. (ALPMY) Ditches AVEO Oncology (AVEO) Pact As Cancer Drug, Tivozanib, Strikes Out Once Again 2/14/2014 7:18:49 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO), Astellas Pharma Inc. (ALPMY) Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer 1/30/2014 7:14:31 AM    More...
Thousands Of Prostate Patients Denied Astellas Pharma Inc. (ALPMY) Drug That Can Extend Life In Watchdog U-Turn 1/28/2014 8:00:19 AM    More...
Astellas Pharma Inc. (ALPMY) Strikes Pact With ClearPath To Build Vaccines Franchise 1/6/2014 6:46:22 AM    More...
Medivation, Inc. (MDVN) And Astellas Pharma Inc. (ALPMY) Initiate Phase 2 Study Of Enzalutamide in Advanced Breast Cancer That Is Estrogen or Progesterone Receptor Positive And HER2 Normal 12/4/2013 10:11:57 AM    More...
12345678910...

//-->